You are here

Revive Therapeutics Ltd.

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
RVV
CSE Index: 
Currency: 

Revive Therapeutics Ltd. is a life sciences company focused on the research and development of therapeutics for infectious diseases and rare disorders, and it is prioritizing drug development efforts to take advantage of several regulatory incentives awarded by the FDA such as Orphan Drug, Fast Track, Breakthrough Therapy and Rare Pediatric Disease designations.  Currently, the Company is exploring the use of Bucillamine for the potential treatment of infectious diseases, with an initial focus on severe influenza strains including COVID-19.  With its recent acquisition of Psilocin Pharma Corp., Revive is advancing the development of Psilocybin-based therapeutics in various diseases and disorders. Revive’s cannabinoid pharmaceutical portfolio focuses on rare inflammatory diseases and the Company was granted FDA orphan drug status designation for the use of Cannabidiol (CBD) to treat autoimmune hepatitis (liver disease) and to treat ischemia and reperfusion injury from organ transplantation.  For more information visit www.ReviveThera.com.  

You are here

Revive Therapeutics Ltd. (RVV)

SEDAR Information

Company Info

Address
The Canadian Venture Building
82 Richmond Street East
Toronto, ON M5C 1P1
Canada
Phone
905-605-5535
Fax
905-248-3355
Email
info@revivethera.com
Website
http://www.revivethera.com
Listing date
Tuesday, July 23, 2019
Transfer Agent
Computershare Investor Services Inc.

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
189,408,777
Reserved for Issuance: 
77,666,709

Bulletins

Advertisement

Publicité

Latest CSE News

Upcoming Events

2020-07-03-Tech-Tuesday_Transportation_Newsletter_Website

Tech Tuesdays

Tuesday, July 14, 2020 -
4:15pm to 5:00pm
07-15_Virtual_Industry_Updates_Tech_Strikes_Back_Website

Virtual Industry Updates: Tech Strikes Back

Wednesday, July 15, 2020 -
3:00pm to 4:15pm
08-12_Virtual_Industry_Updates_Whats_Next_for_the_Cannabis_Industry_Imagery_Website

Virtual Industry Updates: What's Next for the Cannabis Industry?

Wednesday, August 12, 2020 -
3:00pm to 4:15pm